Mira1a Therapeutics announced it raised $6.51 Million in an initial filing from an offering of $6.51 Million

Aug 01, 2022•almost 3 years ago

Amount Raised

$6.51 Million

BaltimoreHealthcare

Company Information

Company

Mira1a Therapeutics

Location

855 N WOLFE STREET #601

Baltimore, Maryland, United States

About

MIRA1a is being developed as the first prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects such as increased appetite and paranoia.

Mira1a Therapeutics announced it raised $6.51 Million in an initial filing from an offering of $6.51 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information